tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Neurotech International Updates Trading Policy to Enhance Compliance
Company AnnouncementsNeurotech International Updates Trading Policy to Enhance Compliance
3d ago
NTI
Neurotech International Issues New Shares, Ensures Regulatory Compliance
PremiumCompany Announcements
Neurotech International Issues New Shares, Ensures Regulatory Compliance
17d ago
NTI
Neurotech International Expands Share Issuance to Boost Market Position
PremiumCompany Announcements
Neurotech International Expands Share Issuance to Boost Market Position
17d ago
NTI
Neurotech International Announces Director Resignation
PremiumCompany Announcements
Neurotech International Announces Director Resignation
17d ago
NTI
Neurotech International Announces Executive Director Resignation
PremiumCompany Announcements
Neurotech International Announces Executive Director Resignation
18d ago
NTI
Neurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
PremiumCompany AnnouncementsNeurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
19d ago
NTI
Neurotech Retracts Market Opportunity Statement
Premium
Company Announcements
Neurotech Retracts Market Opportunity Statement
24d ago
NTI
Neurotech Publishes Positive Phase I/II ASD Trial Results
Premium
Company Announcements
Neurotech Publishes Positive Phase I/II ASD Trial Results
25d ago
NTI
Neurotech International Unveils Strategic Plans at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Neurotech International Unveils Strategic Plans at NWR Virtual Healthcare Conference
30d ago
NTI
Neurotech International to Present at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Neurotech International to Present at NWR Virtual Healthcare Conference
1M ago
NTI
Neurotech International Reports Significant Loss Amid Increased R&D Investment
PremiumCompany Announcements
Neurotech International Reports Significant Loss Amid Increased R&D Investment
2M ago
NTI
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
PremiumCompany Announcements
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
2M ago
NTI
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
PremiumCompany AnnouncementsDirector of Neurotech International Ltd. Increases Stake with Options Acquisition
2M ago
NTI
Neurotech International Issues New Unquoted Equity Options
Premium
Company Announcements
Neurotech International Issues New Unquoted Equity Options
2M ago
NTI
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
Premium
Company Announcements
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
2M ago
NTI
Neurotech International Appoints New CEO with Incentive Plan
PremiumCompany Announcements
Neurotech International Appoints New CEO with Incentive Plan
2M ago
NTI
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
PremiumCompany Announcements
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
3M ago
NTI
Neurotech Advances NTI164 Clinical Trials Amid Regulatory Developments
PremiumCompany Announcements
Neurotech Advances NTI164 Clinical Trials Amid Regulatory Developments
3M ago
NTI
Neurotech International to Expire Listed Options in January
PremiumCompany Announcements
Neurotech International to Expire Listed Options in January
4M ago
NTI
Neurotech International Gains Substantial Investment Stake
PremiumCompany AnnouncementsNeurotech International Gains Substantial Investment Stake
4M ago
NTI
Neurotech Director Increases Shareholding in Company
Premium
Company Announcements
Neurotech Director Increases Shareholding in Company
4M ago
NTI
Neurotech Secures FDA Orphan Drug Status Boost
Premium
Company Announcements
Neurotech Secures FDA Orphan Drug Status Boost
5M ago
NTI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >